ITI Pharma and Healthcare Fund - Dir (IDCW)
Sectoral / Thematic
- NAV 18.45 (0.18%)
- Fund Size (Cr) ₹208.21
- Expense Ratio 0.47
- Scheme Type Active Fund
- Value Research
- Minimum investment ₹5000
- Minimum Additional Investment ₹1000
- Minimum SIP Investment ₹500
- Minimum Withdrawal ₹1000
-
Exit Load
1%
- Return Since Launch 21.99%
Basic Details
Rohan Korde
NIFTY Healthcare TRI
OPEN
Lumpsum Returns
Note: Lumpsum Returns since Inception Date.
SIP Returns
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
-
Investment Type
-
Monthly Investment
₹ -
Expected Returns Rate
% -
Time Period
yrs
Total of your Investment will be
₹ 0
Returns
-
Invested Amount
0
-
Estimated Returns
0
-
Select Scheme
-
Investment Type
-
Monthly Investment
₹ -
Time Period
Total of your Investment will be
₹ 0
Returns
-
Invested Amount
0
-
Estimated Returns
0
Risk Ratios
-
Standard Deviation
4.41% -
Beta
0.89% -
Sharpe Ratio
1.01% -
Treynor’s Ratio
0.41% -
Jension’s Alpha
4.19%
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Peer Comparison
News
-
ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme
ITI Mutual Fund has announced 22 November 2024 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:
ITI Balanced Advantage Fund:
Regular Plan ' IDCW: 0.10
Direct Plan ' IDCW: 0.10
Powered by Capital Market - Live News
-
ITI MF announces change in Fund Manager of the following schemes
ITI Mutual Fund has announced change in Fund Managers of the following schemes with effect from: 15 November 2024
Change in Fund Managers of the Schemes:
Scheme Name Existing Fund Manager(s) New Fund Manager(s) ITI Ultra Short Duration Fund Mr. Vikrant Mehta Mr. Rajesh Bhatia ITI Banking & PSU Debt Fund Mr. Vikrant Mehta Mr. Rajesh Bhatia ITI Dynamic Bond Fund Mr. Vikrant Mehta Mr. Rajesh Bhatia ITI Overnight Fund Mr. Vikrant Mehta Mr. Rajesh Bhatia ITI Liquid Fund Mr. Vikrant Mehta Mr. Rajesh Bhatia ITI Balanced Advantage Fund Mr. Rajesh Bhatia, Mr. Vishal Jajoo and Mr. Vikrant Mehta Mr. Rajesh Bhatia and Mr. Vishal Jajoo and Mr. Rohan Korde ITI Arbitrage Fund Mr. Vikrant Mehta and Mr. Vikas Nathani Mr. Rajesh Bhatia Mr. Vikas Nathani and Mr. Rohan Korde Powered by Capital Market - Live News
-
ITI Mutual Fund Announces Resignation of Key Personnel
ITI Mutual Fund has announced that Mr. Siddhesh Parab, has resigned from the post of Dealer - Equity of ITI Asset Management Private Limited with effect from 11 November 2024.
Powered by Capital Market - Live News
Fund House Details & Investment Objective
- Date of Incorporation 18-Oct-2021
- Total AUM (Cr) ₹208.21
ITI Pharma and Healthcare Fund - Dir (IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, ITI Mutual Fund. Launched in Oct 2021, this fund is managed by Rohan Korde. With assets under management (AUM) worth ₹208.21 (Cr), as of 05-Dec-2024, ITI Pharma and Healthcare Fund - Dir (IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 21.99% since its launch.
The current NAV of ITI Pharma and Healthcare Fund - Dir (IDCW) is ₹18.45, as on 05-Dec-2024. The fund’s benchmark index is NIFTY Healthcare TRI. You can invest in ITI Pharma and Healthcare Fund - Dir (IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units; Nil, if redeemed or switched out after completion of 12 months from the date of allotment of units.
The fund has generated 23.31% and - CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.2% in Equity and 1.8% in cash and cash equivalents
The top 5 sectors the fund invests in are: 77% in Pharmaceuticals & Biotech, 18.01% in Healthcare Services, 1.8% in Cash & Others, 1.2% in Insurance and 1.03% in Fertilisers & Agrochemica.
FAQs on ITI Pharma and Healthcare Fund - Dir (IDCW)
ITI Pharma and Healthcare Fund - Dir (IDCW) is a popular fund in the Sectoral / Thematic segment. The fund has generated a return of 21.99% since inception. Looking to invest in ITI Pharma and Healthcare Fund - Dir (IDCW)? How about earning 1% extra return? All this is possible with m.Stock! Investing in ITI Pharma and Healthcare Fund - Dir (IDCW) is super easy and convenient with m.Stock. Here’s how you can begin:
- Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage across products for life.
- In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
- In the search bar, enter the fund name, in this case, ITI Pharma and Healthcare Fund - Dir (IDCW)
- On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
- If you choose to invest a Lumpsum: Enter amount, select payment mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
- If you choose the SIP route, then enter SIP amount, SIP date, and set up ‘Autopay’ facility.
So, why wait? Invest in ITI Pharma and Healthcare Fund - Dir (IDCW) today and reap the benefits of this Sectoral / Thematic fund!
In the short term, i.e., 1 year, ITI Pharma and Healthcare Fund - Dir (IDCW) has generated annualised return of 48.42%. In the long-term, the fund has generated 23.31% and - in 3 and 5 years respectively. Since its inception, the fund has generated 21.99% returns.
The expense ratio of ITI Pharma and Healthcare Fund - Dir (IDCW) Direct Growth is 0.47%. Expense ratio is the fees payable by investors of the scheme towards management, research and overall upkeep of the fund. The higher the expense ratio, the lower is the in-hand return for the investor. Expense ratio for direct plans is lower than regular plans, making them ideal for investors.
The Assets Under Management (AUM) of ITI Pharma and Healthcare Fund - Dir (IDCW) is ₹208.21 (Cr) as of 05 December 2024. AUM shows the fund’s popularity and is often indicative of fund strength.
Redeeming or selling units of ITI Pharma and Healthcare Fund - Dir (IDCW) is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.
To redeem from ITI Pharma and Healthcare Fund - Dir (IDCW):
- Login to your m.Stock account
- In portfolio, your mutual fund investments will be visible under ‘MF’
- Select the fund you wish to redeem from (in this case ITI Pharma and Healthcare Fund - Dir (IDCW)).
- Click on ‘Redeem’ button
- You have 2 options – redeem by units and redeem by value (you can only redeem free units)
- Select units to be redeemed and click on submit.
- Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).
Yes, you can invest both lumpsum and SIP in ITI Pharma and Healthcare Fund - Dir (IDCW). Minimum lumpsum investment ITI Pharma and Healthcare Fund - Dir (IDCW) is ₹5000 and minimum SIP amount is ₹500. Lumpsum option is ideal for investors with higher investible corpus and market experience. SIP option is recommended for retail investors who do not have the time or expertise to time the market.
The latest NAV (Net Asset Value) of ITI Pharma and Healthcare Fund - Dir (IDCW) is ₹18.45 as on 05 December 2024.
The 5 biggest stock holdings of ITI Pharma and Healthcare Fund - Dir (IDCW) are:
Sun Pharma.Inds. (15.6%), Lupin (6.72%), Suven Pharma (6.06%), Apollo Hospitals (5.42%), Divi's Lab. (4.76%)
A majority of ITI Pharma and Healthcare Fund - Dir (IDCW) 's AUM worth ₹208.21 (Cr) is invested in these 3 top sectors:
- Pharmaceuticals & Biotech: 77%
- Healthcare Services: 18.01%
- Cash & Others: 1.8%